Abstract
Objective: The aim of the present investigation was to carry out a comparative evaluation of skin permeation potential of microemulsion (ME) and niosome based topical gel formulations along with marketed gel products containing diclofenac sodium (DS).
Methods: For ME formulation, solubility studies were done to select optimum oil, surfactant (S) and co-surfactant (CoS). Pseudoternary phase diagrams were constructed using water titration method at different S: CoS ratios to determine ME region. Niosomes were optimized for % drug entrapment using sequential optimization approach for four different factors, surfactant type, solvent ratio, S:Cholesterol ratio and drug amount (mg) at 3 levels. Optimized ME and niosomes were incorporated into carbopol gel base to obtain 1% DS carbopol gel. Both the ME gel and Niosome gel were compared with marketed diclofenac gels. Prepared ME, Noisome gels and marketed A, B and C gels (coded) were evaluated for visual appearance, pH, viscosity, spreadability, mechanical stress studies, % assay and ex vivo skin permeation and retention studies using rabbit skin. Result and Discussion: The pH, spreadability, results of mechanical stress studies and drug content were within the acceptable limits. All gels exhibited pseudoplastic behavior, ME gel showed the highest flowability. The percent drug permeations from different gels were found to be in the range of 19.35% to 57.86 % through rabbit skin over twelve hrs. Marketed gel B showed the highest permeation followed by niosomal gel and ME. However, the release of DS from niosomal gel showed more uniform drug release pattern. Also, the drug retention in the skin after 12 hrs for niosomal gel was significantly higher (44.35%, p < 0.01) followed by ME gel (32.24%, p < 0.05) compared to marketed gels. Conclusion: Our results suggest that the DS niosomal gel significantly enhances both skin permeation and retention and provides more uniform drug permeation through the skin compared to prepared ME and marketed gels.Keywords: Diclofenac sodium, niosomes, microemulsion, gel, skin permeation, skin retention, transdermal drug delivery.
Graphical Abstract
Drug Delivery Letters
Title:Development of Microemulsion and Niosome Based Transdermal Formulations of Diclofenac Sodium and Comparative In Vitro and Ex Vivo Evaluations with Marketed Products
Volume: 7 Issue: 2
Author(s): Tamam Mahmoud Nasser and Aliasgar Shahiwala*
Affiliation:
- Dubai Pharmacy College, Dubai,United Arab Emirates
Keywords: Diclofenac sodium, niosomes, microemulsion, gel, skin permeation, skin retention, transdermal drug delivery.
Abstract: Objective: The aim of the present investigation was to carry out a comparative evaluation of skin permeation potential of microemulsion (ME) and niosome based topical gel formulations along with marketed gel products containing diclofenac sodium (DS).
Methods: For ME formulation, solubility studies were done to select optimum oil, surfactant (S) and co-surfactant (CoS). Pseudoternary phase diagrams were constructed using water titration method at different S: CoS ratios to determine ME region. Niosomes were optimized for % drug entrapment using sequential optimization approach for four different factors, surfactant type, solvent ratio, S:Cholesterol ratio and drug amount (mg) at 3 levels. Optimized ME and niosomes were incorporated into carbopol gel base to obtain 1% DS carbopol gel. Both the ME gel and Niosome gel were compared with marketed diclofenac gels. Prepared ME, Noisome gels and marketed A, B and C gels (coded) were evaluated for visual appearance, pH, viscosity, spreadability, mechanical stress studies, % assay and ex vivo skin permeation and retention studies using rabbit skin. Result and Discussion: The pH, spreadability, results of mechanical stress studies and drug content were within the acceptable limits. All gels exhibited pseudoplastic behavior, ME gel showed the highest flowability. The percent drug permeations from different gels were found to be in the range of 19.35% to 57.86 % through rabbit skin over twelve hrs. Marketed gel B showed the highest permeation followed by niosomal gel and ME. However, the release of DS from niosomal gel showed more uniform drug release pattern. Also, the drug retention in the skin after 12 hrs for niosomal gel was significantly higher (44.35%, p < 0.01) followed by ME gel (32.24%, p < 0.05) compared to marketed gels. Conclusion: Our results suggest that the DS niosomal gel significantly enhances both skin permeation and retention and provides more uniform drug permeation through the skin compared to prepared ME and marketed gels.Export Options
About this article
Cite this article as:
Nasser Mahmoud Tamam and Shahiwala Aliasgar *, Development of Microemulsion and Niosome Based Transdermal Formulations of Diclofenac Sodium and Comparative In Vitro and Ex Vivo Evaluations with Marketed Products, Drug Delivery Letters 2017; 7 (2) . https://dx.doi.org/10.2174/1573404813666170620083504
DOI https://dx.doi.org/10.2174/1573404813666170620083504 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Type 2 Diabetes: An Atherothrombotic Syndrome
Current Molecular Medicine Consideration of Cytokines as Therapeutics Agents or Targets
Current Pharmaceutical Design Adverse Reactions to Iodinated Contrast Media Administered at the Time of Endoscopic Retrograde Cholangiopancreatography (ERCP)
Inflammation & Allergy - Drug Targets (Discontinued) Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs for the Prevention of Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Tocotrienols and Cardiovascular Health
Current Pharmaceutical Design Patent Selections:
Recent Patents on Drug Delivery & Formulation Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Current Medicinal Chemistry Pannexin Channels: The Emerging Therapeutic Targets
Current Drug Targets Energy Provisioning and Inflammasome Activation: The Pivotal Role of AMPK in Sterile Inflammation and Associated Metabolic Disorders
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of Chemokines and Their Receptors in Cancer
Current Pharmaceutical Design Role of T Lymphocytes in the Development of Rheumatoid Arthritis. Implications for Treatment
Current Pharmaceutical Design Update on the Use of Biologics in Lupus
Current Pharmaceutical Biotechnology Potential Novel Anxiolytic Drugs
Current Pharmaceutical Design Combined 3D-QSAR, Pharmacophore and Docking Studies on Benzenesulfonamide Derivatives as Potent 12-Lipoxygenase Inhibitors
Letters in Drug Design & Discovery New Insights into the Pathogenesis of Fibromyalgia Syndrome: Important Role of Peripheral and Central Pain Mechanisms
Current Rheumatology Reviews MicroRNAs in Arterial Remodelling, Inflammation and Atherosclerosis
Current Drug Targets An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies
Current Pharmaceutical Design Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Current Cancer Drug Targets Thrombosis and Nephrotic Syndrome in Children
Current Pediatric Reviews Profiling the Shear Stress of Atherosclerosis; A Genomic View
Current Genomics